N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

Get Full Access

Description

  • N30 Pharmaceuticals is now Nivalis Therapeutics, Inc.Cystic fibrosis (CF) is a multifaceted disease caused by dysfunction of the cystic fibrosistransmembrane conductance regulator (CFTR). The most common mutation, found in 90% of CF patients, is adeletion of phenylalanine at position 508 (F508delCFTR). The correctors currently in clinical developmenttargeting CFTR processing may be limited in effectively treating severe CF airways disease. Therefore, discoveryand development of more efficacious correctors of F508delCFTR continues to be a critically important goal of theCF community.
  • location

    Headquarters:3122 Sterling Cir Ste 200 , Boulder, Colorado, United States

    More
  • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. phone

    Phone Number: +1 303-440-0486

  • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. website

    Website:

  • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. employees

    Employees:5

  • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. revenue

    Revenue:$1 - 10M

  • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. legal name

    Legal Name:N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

  • N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Social Media

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. linkedin N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 424210  |

    Show More
Person level website identification

CEO for N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

Jon Congleton

President And Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Vicki Abbas

Director

Frequently Asked Questions regarding N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

  • Where are N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Headquarters?

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Headquarters are in 3122 Sterling Cir Ste 200 ,Boulder,Colorado,United States

  • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s phone number?

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s phone number is +1 303-440-0486

  • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Revenue?

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s revenue is $1 - 10M

  • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s NAICS code?

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s NAICS code is 424210

  • How many employees are working in N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. has 5 employees

  • What is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Industry?

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc. is in the industry of Biotechnology

  • Who is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s CEO?

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s CEO is Jon Congleton

  • Who is N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Director?

    N30 Pharmaceuticals Is Now Nivalis Therapeutics, Inc.'s Director is Vicki Abbas

Company Directory